2017 AAPB Annual Meeting


Keynote Speaker

KEY1: Keynote Address: Dr. Charles Raison

Thursday, March 16, 2017
6:30 PM to 7:45 PM

Title: Ancient Therapeutics and Sensory Pathways as Deep Brain Stimulators: Implications for the Treatment of Major Depression.

This talk takes as its starting point a disagreement with the current orthodoxy in psychiatric research that mental illnesses are brain disorders. While not minimizing the importance of the central nervous system, in this talk we explore how adopting a different perspective-that of embodied cognition-suggests that conditions such as major depression are systems-based disorders caused by factors that complex, dispersed and interdependent. Far from being a mere squabble over abstractions, this talk suggests that adopting a "brain only" perspective forecloses a number of novel treatment options. We demonstrate this by focusing on two areas central to the speaker's research program: the use of sensory pathways as "deep brain stimulators" and the opportunities afforded to mental health by enhancing our relationships with the microbial world, focusing especially on how health disparities are reflected in disparities in exposure to health-enhancing microbes that track along socioeconomic lines. Finally, we demonstrate how new treatments for depression that are being developed from these embodied perspectives often harken back to ancient practices that have been widely practiced across numerous cultures around the world.

Learning Objectivces

  • Discuss key differences between a brain-centric and an embodied approach to the pathogenesis and treatment of major depression
  • Describe how peripheral sensory pathways hold promise for the treatment of depression, focusing on the potential clinical utility of whole body hyperthermia, Mycobacterium vaccae and dog-human relationships
  • Discuss differences between the behavioral effects of ancient practices discussed in this presentation and the effects of currently available pharmacological treatments for depression.

Who Should Attend:This talk will be of value to anyone treating mental illness as well as researchers studying brain-body mechanisms central to behavior. Level:All

Charles RaisonCharles Raison Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, WI. Prior to this he was Professor in the Department of Psychiatry, College of Medicine, and the Barry and Janet Lang Professor of Integrative Mental Health at the Norton School of Family and Consumer Sciences, College of Agriculture and Life Sciences, University of Arizona. In addition to his academic positions, Dr. Raison serves as the founding Director of the Center for Compassion Studies in the College of Social and Behavioral Sciences at the University of Arizona and the mental health expert for CNN.com. Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training.

 

KEY2: Keynote Address by Daniel Amen - The Brain Warrior's Way

Friday, March 17, 2017
9:15 AM to 10:30 AM

The Brain Warrior's Way

The Brain Warrior's Way is a unique and powerful program and the only one of its kind to improve the health of your brain and body. In this course, Daniel G. Amen MD, teaches you how to develop the Brain Warrior's M.A.S.T.E.R.Y. over your physical and mental health. The Brain Warrior's Way is a way of living, a clear path developed over three decades of helping over tens of thousands of patients improve their energy, focus, mood, memory, weight, relationships, work and overall health.

Speaker:

  • Daniel Amen, MD, Board Certified, American Board of Psychiatry and Neurology, General Psychiatry

Who Should Attend: All

Level: All

Daniel AmenDaniel Amen Dr. Amen is a physician, double board certified psychiatrist and ten-time New York Times bestselling author. He is the Founder and CEO of Amen Clinics in Costa Mesa and San Francisco, California, Bellevue, Washington, Reston, Virginia, Atlanta, Georgia and New York City. Amen Clinics have the world's largest database of functional brain scans relating to behavior, totaling nearly 100,000 scans on patients from 111 countries. Dr. Amen is a Distinguished Fellow of the American Psychiatric Association, the highest award they give members, and is the lead researcher on the world's largest brain imaging and rehabilitation study on professional football players. His research has not only demonstrated high levels of brain damage in players, he also showed the possibility of significant recovery for many with the principles that underlie his work. Together with Pastor Rick Warren and Dr. Mark Hyman, Dr. Amen is also one of the chief architects on Saddleback Church's "The Daniel Plan," a 52-week program to get people healthy through their religious organizations.

 

KEY3: Special Keynote Presentation by Dr. Chris Morris

Friday, March 17, 2017
12:45 PM to 1:45 PM

Heart Rate Variability: Bridging the gap between Physical and Mental Performance Coaches

The use of heart rate variability has witnessed a sharp increase in the world of elite athletics over the past several years. Members of both the strength and conditioning and mental performance communities use HRV to increase performance. However, their interpretation and utilization differ significantly. This session highlights the use of heart rate variability in collegiate athletics and its application to the identification of athletes functional state. This functional state represents how adaptable an athlete may be to a training load on a given day and serves to identify athletes who fail to adapt over a series of training sessions. The same mechanisms that drive the theories behind its use in physical performance also play a major role in mental performance. This session will attempt to bridge the gap between physical and mental coaches who work in tandem for one overarching purpose, to increase performance. These ideas should not be viewed as competing, yet complimentary towards developing the athlete both physically and mentally.

Speaker: Chris Morris, PhD - Exercise Science, Director of Performance Science, University of Kentucky

Learning Objectives:

  • Analyze HRV to determine functional states of readiness
  • Assess an athletes ability to receive training loads
  • Create long term strategies to improve athletes susceptibilities to stressors
  • Apply HRV in both mental and physical performance domains

Who Should Attend: Mental and Physical Preparation Coaches, Fitness Enthusiasts

Level: Intermediate

Guidelines Applied in Practice: System-based Practice - This session will provide insight of the use of HRV in the collegiate athletic model. It will discuss perspectives from both mental and physical domains and provide insight on how the two can work more effectively together using HRV to assess an athlete and increase performance.

Chris MorrisChris Morris Dr. Chris Morris joined the University of Kentucky Athletics Department as the Director of Performance Science in August of 2016, coming from the University of Texas where he held a similar position. He is responsible for the strategic direction and coordination of a multi-disciplinary sports science program utilizing a variety of methods and technologies to enhance athletic performance while mitigating the risks of injuries. His research specializes in monitoring the internal loads of athletes in response to training using metrics such as heart rate variability, the direct current potential of brain waves, session ratings of perceived exertion, and wellness questionnaires. He is considered one of the leading authorities on athlete monitoring by Omegawave Inc. and has authored "Omegawave: Theory & Practice," a manual to educate strength and conditioning professionals on the interpretation of Omegawave parameters and subsequent training prescription. He is married to Dr. Lauren Morris who is currently finishing her Orthodontic Residency at the University of Louisville.

 

KEY4: President Lecture - Bessel van der Kolk

Friday, March 17, 2017
6:15 PM to 7:30 PM

Developmental trauma: effects of abuse & neglect on CNS development & a possible role for Neurofeedback to reverse the damage.

Trauma directly affects the developing brain, and specific brain functions responsible for attention, concentration, regulating emotions and engaging in satisfying relationships. This keynote will discuss some of the well established changes. We are currently studying whether neurofeedback can reverse those brain changes. Many traumatized children and adults continue to feel chronically on edge, scared, agitated, collapsed and helpless, even after exposure treatment and medications. To deal with this they often try to cope with alcohol or drugs. Medications that may make life more manageable but they also affect motivation and curiosity, and rarely really lead to increased focus, relaxation and engagement. This lecture reviews the way trauma impacts on brain development and show the effects of neurofeedback.

Speaker:

  • Bessel van der Kolk, BA, MD, Medical Director, Principal Investigator, Trauma Center
Learning Objectives:
  • This lecture will review recent developments in neuroscience as they relate to the treatment of PTSD.
  • This lecture will review recent developments in the treatment of PTSD, and the effects
  • Describe the acquisition of affect regulation and execitve functioning through neurofeedback.

Bessel Van Der KolkBessel Van Der Kolk Bessel A. van der Kolk, M.D. has been the Medical Director of The Trauma Center in Boston for the past 30 years. He is a Professor of Psychiatry at Boston University Medical School and serves as the co-director of the National Center for Child Traumatic Stress Complex Trauma Network. He is past President of International Society for Traumatic Stress Studies. Though he identifies himself primarily as a clinician, he has published well over 150 peer reviewed scientific articles on various aspects of trauma, including his current projects: 1) yoga for treating PTSD, funded by the National Institutes of Health; 2) the use of theater for violence prevention in the Boston public schools, funded by the CDC; 3) the mechanisms of EMDR; 4) sensory integration in traumatized children; and 5) the use of neurofeedback in PTSD. He has written extensively using neuroscience research to identify appropriate treatments for PTSD and completed the first NIMH-funded study of EMDR. He has taught at universities and hospitals around the world. He is author of the New York Times bestselling book The Body Keeps the Score: Mind, Brain and Body in Healing From Trauma . Viking Penguin, 2014.

 

KEY6: Keynote Presentation: Science and Clinical Application of Instantaneous...

Saturday, March 18, 2017
9:30 AM to 10:30 AM

Title: Science and Clinical Application of Instantaneous Z-Score Neurofeedback

The objectives are to explain and present the, history, science and clinical applications of Instantaneous Z-ScoreNeurofeedback (NFB). The two presenters will spit time and present their different histories and differentapproaches to instantaneous Z-score NFB. The topics will include the technical underpinnings of the computation ofinstantaneous z-scores using a reference database and clinical evidence that the proposed mechanism are supportedby electrophysiological and outcome data. Special emphasis will be placed on scientific standards of instantaneous Zscoresand comparisons to standard raw Z score NFB will be discussed. Both presenters will provide demonstrationsof different methods of implementing Z-score NFB

Robert ThatcherRobert Thatcher Dr. Robert Thatcher received a B.S. degree in Chemistry from the University of Oregon and a Ph.D. in biopsychology from the University of Waterloo. From 1971-72, he was a NIH postdoctoral fellow in neurobiology and neurophysiology at the Albert Einstein College of Medicine before joining the faculties of New York Medical College and NYU School of Medicine. From 1979 to 1999, Dr. Thatcher was a professor of Psychiatry at the University of Maryland before joining the faculty of the National Institutes of Health as the program manager for the 1st 128 channel EEG system where he served on the National Institutes of Health Scientific Advisory Committee for the NIH Human Brain Map Project. From 1993 to 2001 Dr. Thatcher was the director of the NeuroImaging Laboratory at the Bay Pines VA Medical Center, Bay Pines, Florida, and was an adjunct professor in the Departments of Neurology and Radiology at the University of South Florida also the EEG and MRI principal investigator for the Department of Defense and Veterans Administration Head Injury Program (DVHIP). He served as Sargent of Arms on the board for ISNR in 1998-1999, in 1999 - 2001 he severed on the board of the American Board of Electroencehalography and Neurophysiology (ABEN) and from 1999 to 2004 he served on the board as Secretary for the EEG and Clinical Neuroscience Society (ECNS). In 1998 he was awarded the "Life Time Achievement Award for Work in the Scientific Specialty of QEEG", by the American Board of Certification of Quantitative Electroencephalography, in 2008 he was the recipient of the AAPB "Hans Berger Award of Merit" and in 2009 he was awarded the ISNR "Life Time Achievement Award". In 2012 along with co-authors he received the Best Paper Award: "Differentiating transformational and non-transformational leaders on the basis of neurological imaging". Published in The Leadership Quartertly, 2012. Sponsored by the Center for Creative Leadership. He is the inventor/developer of NeuroGuide software for QEEG and Neurofeedback and is the author of over 200 publications, including eight books. His most recent books are the "Handbook of Quantitative Electroencephalography and EEG Biofeedback" and "Z Score Neurofeedback: Clinical Applications" (co-edited with Dr. Joel Lubar). He is currently the director of the Applied Neuroscience Research Institute and the President & CEO of Applied Neuroscience, Inc.

Thomas ColluraThomas Collura Thomas F. Collura, Ph.D., MSMHC, QEEG-D, BCN, NCC, LPCC is Clinical Director at the Brain Enrichment Center. He earned his doctorate from Case Western Reserve University in Biomedical Engineering with a concentration in Neuroscience, and also has undergraduate degrees from Brown University in Philosophy and Biology. He has been on the staff of the Department of Neurology, Cleveland Clinic, as a neurological computing scientist and clinical instructor in neurophysiology, and has been an Adjunct Assistant Professor at Case Western Reserve University School of Medicine. He completed his Master's degree in Mental Health Counseling from Walden University and is a National Certified Counselor as well as board certified in Quantitative EEG and in Neurofeedback. He is the author of "Technical Foundations of Neurofeedback" published by Taylor/Francis. He is a Past President of the International Association for Applied Psychophysiology and Biofeedback (AAPB)

 

KEY7: AAPB Distinguished Scientist Presentation

Saturday, March 18, 2017
5:15 PM to 6:30 PM
Title: Is Neurofeedback of Slow Cortical Potentials in Children with ADHD Specific? A summary of Design and Results of the German Multicenter Study on SCP-Feedback.

Neurofeedback (NF) in children with ADHD has been investigated in a series of studies. Although most of the studies reported favorable outcomes, the question of specificity has not been answered unanimously. In a multicenter study including 144 children, efficacy of SCP feedback was compared with a semi-active electromyographic feedback (EMG), controlling for unspecific effects of treatment. Both groups were randomized and trained in an identical setting. The only difference referred to the target of self-regulation. As a primary outcome both groups showed reduced symptoms according to parents ratings. NF was superior over EMG (significant treatment difference, p=0.023). The Effect size was d=0.57 without and 0.40 with Baseline observation carried forward (BOCF). Only NF showed successful self-regulation of EEG. Adverse events and serious adverse events were assessed based on the criteria for clinical studies. As a result, no severe side effects were observed. The very few adverse events observed remitted quickly and had no influence on the treatment schedule. It was concluded that based on both specific and unspecific effects SCP-FB is feasible and efficacious.

Speakers:

  • Ute Strehl, M.Sc., PhD

  • Learning Objectives:

    • Discuss the placebo issue in NF Research
    • Describe the outcome of SCP-FB research
    • Critical evaluation of study designs
    • Explain to patients, colleagues, and media why SCP-NF is specific

    Who Should Attend:
    Clinicians and researcher interested in the evidence base of SCP-Feedback.

    Level: Intermediate

    Guidelines Applied in Practice: Professionalism - While practitioners have been using NF in ADHD successfully for years, the scientific community in psychiatry and psychology is still questioning its evidence base. This is justified by poorly designed research in the early years of NF and lately because meta-analyses show divergent results. The study seeks to disentangle the diverse demands of the critics with an innovative design. Its results will help to discuss the demands and to highlight the specific clinical merits of NF.

Ute StrehlUte Strehl Ute Strehl, Ph.D., is a licensed clinical psychologist and Assistant Professor (Emeritus) at the Institute for Medical Psychology and Behavioral Neurobiology of the Eberhard-Karls University of Tübingen, Germany. Her research focuses on the development of behavioral treatments for neurological disorders such as Epilepsy, Parkinson's Disease, and Attention Deficit-Hyperactivity Disorder. She is the recipient of multiple awards for her teaching, research, and publications. In 2010 she was honoured by the Biofeedback Foundation of Europe with the "Exceptional Achievement Award" for outstanding contribution to the EEG field through her research on Slow Cortical Potentials. Among other publications, she authored the "EEG-Primer" and "Biofeedback of Slow-Cortical Potentials" chapters in the newest edition of the well-known "Biofeedback: A Practitioner's Guide", edited by Schwartz & Andrasik.

 
 
Back To Top